Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$829.2M
29M shares
52-week range
$19.50 – $31.11
82% from low
Sector
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
Exchange
NASDAQ
CS
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
www.healthstream.comNo one on the platform currently holds HSTM.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 477,848 | $9.9M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-17 | $0.0350 | 2026-08-28 |
| 2026-05-18 | $0.0350 | 2026-05-29 |
| 2026-03-09 | $0.0350 | 2026-03-20 |
| 2025-11-17 | $0.0310 | 2025-11-28 |
| 2025-08-18 | $0.0310 | 2025-08-29 |
| 2025-05-19 | $0.0310 | 2025-05-30 |
| 2025-03-10 | $0.0310 | 2025-03-21 |
| 2024-11-04 | $0.0280 | 2024-11-15 |
| 2024-08-05 | $0.0280 | 2024-08-16 |
| 2024-05-03 | $0.0280 | 2024-05-17 |
No one on the platform has traded HSTM yet.
| 2024-03-08 | $0.0280 | 2024-03-22 |
| 2023-12-08 | $0.0250 | 2023-12-22 |
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$HSTM Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.23 up 27.78% YoY • Reported revenue of $83.73M up 12.55% YoY • HealthStream is updating its full year 2026 guidance, now expecting revenue between $327.0 million and $332.0 million, net income of $19.5 million to $22.2 million, and adjusted EBITDA of $74.0 million to $78.0 million.
View on StockTwits ↗$HSTM is showing strong revenue momentum, but the quality of that growth matters. Some of the recent upside came from one-time factors, so the key question is whether the business can keep the growth trend going while improving margins.
View on StockTwits ↗Wall St is expecting 0.19 EPS for $HSTM Q3 [Reporting 10/26 AMC] http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$HSTM UP 20%+ 🔥 Called on https://t.me/veltrixcapitalbrokers
View on StockTwits ↗$HSTM stock and options are mispriced - going much higher.
View on StockTwits ↗HSTM ripping higher into the close and showing real juice after that Q1 beat. Check it: $HSTM is up strong with shares trading around mid‑20s action, pushing past yesterday’s levels and pulling a fresh bid into late session. Earnings came in hotter than analyst targets with EPS of $0.20 vs expectations of ~$0.17 and revenue up ~10.5% YOY, giving bulls something to latch onto. The intraday price action is showing buyers stepping in off key support, and with a new dividend announced plus a $10M buyback in place, the setup is acting like a squeeze on lighter supply. If this close holds, we’re looking at follow‑through momentum into tomorrow’s open with conviction from both fundamentals and tape. Don’t blink.
View on StockTwits ↗$HSTM Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.20 up 42.86% YoY • Reported revenue of $81.2M up 10.50% YoY • HealthStream reaffirms full year 2026 guidance: revenues are expected between $323M and $330M, net income from $20.4M to $22.8M, and Adjusted EBITDA from $73M to $77M.
View on StockTwits ↗Wall St is expecting 0.18 EPS for $HSTM Q2 [Reporting 07/27 AMC] http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗Wall St is expecting 0.17 EPS for $HSTM Q1 [Reporting 05/04 AMC] http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$HSTM Share Price: $21.43 Contract Selected: Dec 18, 2026 $25 Calls Buy Zone: $0.88 – $1.09 Target Zone: $1.54 – $1.88 Potential Upside: 65% ROI Time to Expiration: 234 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Wall St is expecting 0.18 EPS for $HSTM Q1 [Reporting 04/27 AMC] http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗Wall St is expecting 0.18 EPS for $HSTM Q1 [Reporting 04/27 AMC] http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$HSTM reported 12.50% YoY EPS growth for Q4, up from 5.26% in Q3. http://www.estimize.com/intro/hstm?chart=historical&metric_name=eps&utm_c
View on StockTwits ↗$HSTM Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.09 down -43.75% YoY • Reported revenue of $79.71M up 7.37% YoY • HealthStream anticipates full-year 2026 revenues between $323M and $330M, with Adjusted EBITDA projected to be $73M to $77M. Net income is expected to range from $20.4M to $22.8M.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $329M | +9.4% | $0.74 | $0.73–$0.75 | 39.0× | 2 |
| 2027 | $344M | +4.6% | $0.82 | $0.81–$0.82 | 35.4× | 3 |
| 2028 | $361M | +5.0% | $0.00 | $0.00–$0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-03 | $0.17 | $0.23 | +38.6% |
| 2026-05-04 | $0.16 | $0.20 | +25.0% |
| 2026-02-23 | $0.16 | $0.18 | +12.5% |
| 2025-11-03 | $0.17 | $0.20 | +17.6% |
| 2025-08-04 | $0.16 | $0.18 | +12.5% |
| 2025-05-05 | $0.16 | $0.14 | -12.5% |
| 2025-02-24 | $0.13 | $0.16 | +23.1% |
| 2024-10-21 | $0.13 | $0.19 | +46.2% |
| $2.2B |
| — |
| EVHEvolent Health, Inc. | $4.66 | +11.75% | $524M | — |
| GLUEMonte Rosa Therapeutics, Inc. | $15.84 | -0.69% | $1.3B | — |
Source: Financial Modeling Prep · peers by sector/industry